Revenue Cycle Management Market to Reach $367.7 Billion by 2031

The global market for Revenue Cycle Management (RCM) is expected to reach $367.7 billion by 2031, according to a new report by Allied Market Research. The market was valued at $109.53 billion in 2021 and is projected to grow at a compound annual growth rate of 13.2% from 2022 to 2031.

The growth is attributed to the increasing demand for workflow optimization within healthcare organizations and the adoption of synchronized management software systems. Stricter regulations, underpayments, and longer payment delays faced by healthcare providers are also fueling the need for efficient RCM solutions that encompass all clinical and administrative activities related to patient revenue generation and collection.

Technological advancements, particularly the integration of artificial intelligence (AI) and machine learning (ML) into RCM solutions, are significant growth drivers. A notable collaboration in this area is between Cerner and AKASA, announced in May 2022, which aims to automate revenue cycle tasks using an AI-driven platform. Software currently holds the largest market share, but the services segment is anticipated to exhibit the highest growth rate due to the rise in cloud-based RCM and demand for professional services.

Regionally, North America dominated the market in 2021. However, the Asia-Pacific region is expected to witness the highest growth rate due to increasing healthcare spending and technological advancements. The COVID-19 pandemic did not negatively impact market growth and is expected to present further opportunities for the RCM market.